Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain
Daniel A. Culver(Cleveland Clinic), Michael Brines(Northwell Health), Anthony Cerami(Araim Pharmaceuticals (United States)), Rayaz A. Malik(Manchester Academic Health Science Centre), Jinny Tavee(National Jewish Health), Rita I. Kirk(Araim Pharmaceuticals (United States)), Monique van Velzen(Leiden University Medical Center), Ioannis N. Petropoulos(Manchester Academic Health Science Centre), Albert Dahan(Centre for Human Drug Research), Ann Dunne(Araim Pharmaceuticals (United States)), Maria Jeziorska(University of Manchester), Martijn R. Tannemaat(Leiden University Medical Center), Leon Aarts, Daiva Bajorunas(Araim Pharmaceuticals (United States))
Cited by 103
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Decontamination of the Digestive Tract and Oropharynx in ICU Patients
|New England Journal of Medicine|2008|823